'Secondary outcome' presentation slideshows

Fatty Liver Disease

Fatty Liver Disease. Jamie Blazek, MPH, APRN, FNP-C Liver Transplant Department Ochsner Health Systems New Orleans, La. Disclosures. None. Objectives. Identify risk factors for fatty liver disease Order appropriate screening tests Diagnose and treat fatty liver disease

1.56k views • 63 slides

Evidence - based medicine

Evidence - based medicine. Course: Research in Biomedicine and Health III Seminar 4: Critical assessment of evidence. What is EBM in practice ?. EBM steps Step 1: Formulating questions that can be answered Step 2: Finding best evidence Step 3: Quick critical assessment of the evidence

558 views • 53 slides

The efficacy of Vancomycin as a first line treatment of Clostridum Difficile and its effect on length of hospital stay

The efficacy of Vancomycin as a first line treatment of Clostridum Difficile and its effect on length of hospital stay. Medhat Barsoom, M.D. , Kosta Botsoglou , M.D. , Orooj Khan, M.D., Gopichand Pendurti , M.D. Michael Hocko , M.D. Introduction.

676 views • 49 slides

Diabetes and CKD- The update

Diabetes and CKD- The update. Dr Ching Chen Hua. Kidneys play a critical role in the management of glucose reabsorption and maintaining the overall metabolic balance in humans.

438 views • 37 slides

Acute pulmonary embolism: MDCT & biomarkers

Acute pulmonary embolism: MDCT & biomarkers. Cecilia Becattini University of Perugia. Acute pulmonary embolism: MDCT & biomarkers. MDCT to diagnose PE MDCT for prognostic stratification serum biomarkers. Acute pulmonary embolism: MDCT & biomarkers. MDCT to diagnose PE

571 views • 28 slides

Current Progress on Advanced Systems for Glycomics Sample Preparation Split, 10-2-2013.

Current Progress on Advanced Systems for Glycomics Sample Preparation Split, 10-2-2013. Illkirch, June 2011. Outline of MP Bio Presentation. Introduction Scientific Portion: Surface chemistry of enzymes important for glycan sample preparation Kits for glycoproteins extractions

422 views • 27 slides

Anticholinergic Poisoning

Anticholinergic Poisoning. Andrew Dawson, Newcastle Mater Hospital Robert Hoffman, New York Poison Centre. Belladonna. Atropa belladonna (Solanaceae). Kinetics. Rapidly absorbed Prolonged absorbtion in overdose Large volume of distribution and rapid distribution Low hepatic clearance.

374 views • 25 slides

RF ICs and mm-Wave ICs Saurabh Sinha, PhD (Eng)

RF ICs and mm-Wave ICs Saurabh Sinha, PhD (Eng) Microelectronics & Electronics Group University of Pretoria, South Africa Friday, 22 August 2014. Departement Elektriese, Elektroniese & Rekenaar-Ingenieurswese Department of Electrical, Electronic & Computer Engineering

367 views • 24 slides

TRANSCEND

TRANSCEND: T elmisartan R andomized A ssesme N t S tudy in a CE i N tolerant S ubjects with C ardiovascular D isease. TRANSCEND. Question: Is telmisartan superior to placebo in patients at high risk of CV events who are intolerant of ACE-I? Outcome:

487 views • 22 slides

TRANSCEND

TRANSCEND: T elmisartan R andomized A ssesme N t S tudy in a CE i N tolerant S ubjects with C ardiovascular D isease ONTARGET / TRANSCEND Investigators Koon K. Teo , MB, PhD, FRCPC. Question :

329 views • 19 slides

Valentin Fuster MD, PhD, on behalf of the Fifty-Fifty Trial Investigators

Impact of a Comprehensive Lifestyle Peer Group-Based Intervention on CV Risk Factors: A Randomized Controlled Trial. Valentin Fuster MD, PhD, on behalf of the Fifty-Fifty Trial Investigators American Heart Association Annual Scientific Sessions 2015. Steering Committee. Background.

167 views • 16 slides

TRANSCEND

TRANSCEND: T elmisartan R andomized A ssesme N t S tudy in a CE i N tolerant S ubjects with C ardiovascular D isease ONTARGET / TRANSCEND Investigators Koon K. Teo, MB, PhD, FRCPC Disclosure Statement: Received Research Grants and Honoraria from Boehringer Ingelheim. TRANSCEND. Question:

314 views • 14 slides

674 views • 12 slides

Engaging in broadband policy and regulatory processes Fine-tuning & framing a policy proposal

315 views • 10 slides